Literature DB >> 1943329

Use of microorganisms for the study of drug metabolism: an update.

A M Clark1, C D Hufford.   

Abstract

The use of microorganisms as tools in the study of drug metabolism appears to be gaining popularity. The selected examples cited here provide additional evidence of the utility of these systems as alternative in vitro models for studying drug metabolism in humans. However, as was noted earlier, this model, nor any other in vitro model system could ever replace animals in biomedical research. However, it is apparent from the numerous examples cited here and in the previous review of this area that microorganisms are a reliable, reproducible alternative to small animals as predictive models in drug metabolism studies. The continuing development of techniques that reduce the use of animals in research is encouraged and this procedure appears to be gaining more widespread acceptance for such use.

Entities:  

Mesh:

Year:  1991        PMID: 1943329     DOI: 10.1002/med.2610110503

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  13 in total

1.  Microbial production of a crisnatol metabolite.

Authors:  C D Hufford; S H el-Sharkawy; T M Jurgens; J R Mikell
Journal:  Pharm Res       Date:  1992-05       Impact factor: 4.200

2.  Microbial metabolism of the beta-adrenoreceptor antagonist bisoprolol.

Authors:  H Schwartz; R E Licht; H E Radunz
Journal:  Appl Microbiol Biotechnol       Date:  1993-11       Impact factor: 4.813

3.  Microbial oxidation of ebastine.

Authors:  H Schwartz; A Liebig-Weber; H Hochstätter; H Böttcher
Journal:  Appl Microbiol Biotechnol       Date:  1996-02       Impact factor: 4.813

4.  Transformation of amoxapine by Cunninghamella elegans.

Authors:  J D Moody; D Zhang; T M Heinze; C E Cerniglia
Journal:  Appl Environ Microbiol       Date:  2000-08       Impact factor: 4.792

5.  Biotransformation of the antimelanoma agent betulinic acid by Bacillus megaterium ATCC 13368.

Authors:  P Chatterjee; S A Kouzi; J M Pezzuto; M T Hamann
Journal:  Appl Environ Microbiol       Date:  2000-09       Impact factor: 4.792

6.  Microbial Demethylation of Immunosuppressant FK-506: Isolation of 31-O-FK-506-Specific Demethylase Showing Cytochrome P-450 Characteristics from Streptomyces rimosus MA187.

Authors:  A Shafiee; T Chen; P Cameron
Journal:  Appl Environ Microbiol       Date:  1995-10       Impact factor: 4.792

7.  Microbial and mammalian metabolism studies on the semisynthetic antimalarial, deoxoartemisinin.

Authors:  S I Khalifa; J K Baker; M Jung; J D McChesney; C D Hufford
Journal:  Pharm Res       Date:  1995-10       Impact factor: 4.200

8.  Microbial and mammalian metabolism studies of the semisynthetic antimalarial, anhydrodihydroartemisinin.

Authors:  S I Khalifa; J K Baker; R D Rogers; F S el-Feraly; C D Hufford
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

9.  Specific 12 beta-hydroxylation of cinobufagin by filamentous fungi.

Authors:  Min Ye; Guiqin Qu; Hongzhu Guo; Dean Guo
Journal:  Appl Environ Microbiol       Date:  2004-06       Impact factor: 4.792

10.  Biocidal action of chlorhexidine is annulled by nicotinic acid.

Authors:  H Baker; O Frank; B DeAngelis; E R Baker
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.